spacer
The Healthcare Sales & Marketing Network celebrates 25 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  ketorolac tromethamine  

 HSMN NewsFeed - 22 Dec 2020
Nephron Announces FDA Approval of Ketorolac, Signaling New Phase of Growth
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 29 May 2018
Egalet Announces Large Regional Plan to Cover SPRIX(R) Nasal Spray
Biopharmaceuticals Reimbursement
 HSMN NewsFeed - 17 May 2010
ROXRO Announces FDA Approval of SPRIX(TM)
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 23 Jul 2009
Allergan Receives FDA Approval for ACUVAIL Ophthalmic Solution for the Treatment of Pain and Inflammation Following Cataract Surgery
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 12 Nov 2007
ISTA Pharmaceuticals Presents Results from Two Phase III Clinical Trials of Xibrom(TM) QD (Once-daily) Formulation at the American Academy of Ophthalmology Annual Meeting
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 12 Apr 2007
U.S. Federal Circuit Court Affirms Judgment for Allergan, Inc. and Roche Palo Alto, LLC against Apotex, Inc., Apotex Corp., and Novex Pharma in Ketorolac Patent Infringement Lawsuit
Biopharmaceuticals Ophthalmology Generics Litigation
 HSMN NewsFeed - 12 Sep 2006
Javelin Pharmaceuticals, Inc. To Present Final Analysis of Phase 2b Study Results of Dyloject(TM) at Prestigious European Pain Conference - September 14, 2006
Biopharmaceuticals
 HSMN NewsFeed - 5 Jun 2006
Allergan Wins ACULAR(R) Patent Infringement Lawsuit Against Apotex, Inc., Apotex Corp., and Novex Pharma
Biopharmaceuticals Ophthalmology Generics Litigation
 HSMN NewsFeed - 4 May 2006
ISTA Pharmaceuticals(R) Announces Study Indicating Twice-Daily Dosing of Xibrom(TM) as Equivalent to Four Times a Day of Other Treatments
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 23 Jan 2006
Preliminary Phase IIb Study Shows Dyloject(TM) Relieves Postoperative Pain Faster Than Ketorolac
Biopharmaceuticals
 HSMN NewsFeed - 3 Jan 2006
Allergan Granted Temporary Restraining Order in ACULAR(R) Patent Infringement Case
Biopharmaceuticals Ophthalmology Generics Litigation
Return to NewsFeed  

 Additional items found! 5

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 5 additional stories matching:
ketorolac tromethamine
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.